Douglas E. Peterson, DMD, PhD, FDS RCSEd, FASCOProfessor Emeritus of Oral Medicine, Oral & Maxillofacial Diagnostic Sciences
|
Dr. Peterson began his faculty career in 1976 in the Cancer Center and Dental School of the University of Maryland, with continuation through 1989. He served as Visiting Scholar at the Fred Hutchinson Cancer Research Center in 1983, and was Consultant in Oral Medicine to the National Institutes of Health (NIH) from 1988-1994. Dr. Peterson was also appointed as associate medical staff at The Johns Hopkins Hospital and Oncology Center from 1988-1991. He served as Professor and Head, Dept/ of Oral Diagnosis, University of Connecticut School of Dental Medicine between 1989-2005, and again as Interim Department Head 2006-2007. He is currently one of two Chairs of the Interprofessional Education curriculum at UConn Health.
Dr. Peterson’s primary academic responsibilities throughout his career have been directed to oral management of the medically complex patient, with emphasis on oral complications in cancer patients. He has contributed to development of interprofessional models for patient care, research and health professional education in this context for more than 45 years. His leadership contributed to creation of the alliance between Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Oral Oncology (ISOO) in 1998. He has lectured extensively at regional, national, and international levels for over four decades.
Dr. Peterson is author of more than 210 peer-reviewed publications and 160 abstracts. He is editor of two books as well as two JNCI Monographs, including the 2019 JNCI Monograph addressing oral complications in oncology patients. He has been involved in translational and clinical trial research in the oncology setting throughout his career, including serving as Principal Investigator (PI) on two multi-center, international clinical trials involving drug development for oral mucositis in cancer patients. He has also served as PI on multiple NIH grants including R01's and R13's as well as primary mentor for the K Award program.
Dr. Peterson has been reviewer of grant applications for the NIDCR and NCI on a frequent basis during the past 35 years, including study section chair for several panels. He has also been Special Government Employee for the United States Food & Drug Administration for mucositis clinical trials. Dr. Peterson has served as lead writer for the NCI’s PDQ® website Oral Complications of Chemotherapy and Head/Neck Radiation for the past 15 years, and is currently leading the strategic revision for publication in 2024. Dr. Peterson has been a frequent contributor to CancerCare for many years, and received CancerCare’s Physician-of-The-Year award in 2006. In recognition of his career contributions Dr. Peterson received the FDS RCSEd Without Examination from the Royal College of Surgeons/Edinburgh in 2011. He was appointed in March 2015 to the Faculty of Examiners for the Conjoint FDS Examination in Oral Medicine, and as a Regional Dental Advisor for the College effective April 2015.
Dr. Peterson chaired the NIH-funded conference Oral Complications of Emerging Cancer Therapies in April 2009. He also chaired an American Society of Clinical Oncology (ASCO) Education Session in June 2012 titled “Mucosal injury in patients with cancer: Targeting the biology”. Dr. Peterson has been Co-chair of ASCO’s Supportive Care Guideline Advisory Group, as well as recent Chair of ASCO's Clinical Practice Guidelines Committee and Chair of ASCO’s Methodology Subcommittee. He received the Fellow of the American Society of Clinical Oncology award in 2022, and is currently contributing a leadership role in developing joint oral oncology guidelines in collaboration with ASCO and MASCC/ISOO.
Degree | Institution | Major |
---|---|---|
BA | Colgate University | Biology |
DMD | University of Pennsylvania School of Dental Medicine | Dental Medicine |
Diplomate | University of Pennsylvania School of Dental Medicine | Oral Medicine Residency Program |
PhD | University of Pennsylvania School of Arts & Sciences | Experimental Pathology |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Residency | University of Pennsylvania School of Dental Medicine | Oral Medicine |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Distinguished Faculty Award in recognition of leadership and commitment to UConn School of Dental Medicine (Farmington, CT) (2024) | UConn School of Dental Medicine Alumni Association |
The Outstanding Publication Award in recognition of first authorship role for a publication in a leading academic journal on topic related to supportive cancer care (Lille, France) (2024) | Multinational Association of Supportive Care in Cancer |
Fellow, American Society of Clinical Oncology (FASCO) (Chicago, IL) (2022) | American Society of Clinical Oncology |
King James IV Professorship (Edinburgh, Scotland) (2022) | Royal College of Surgeons of Edinburgh |
Faculty Recognition Award in recognition of academic, administrative and/or clinical excellence (presented annually to a UConn Health faculty member at UConn Health Commencement) (Storrs, CT) (2018) | UConn Health Board of Directors |
Distinguished Service Award (inaugural year of award) (Adelaide, Australia) (2016) | International Society of Oral Oncology |
Invited lectures: 1st Chilean International Symposium on Oral Care in Oncology (Santiago, Chile) (2015) | Chilean International Symposium on Oral Care in Oncology |
Chair, Am Soc Clin Oncol Annual Meeting Education Session (Chicago, IL) (2012) | American Society of Clinical Oncology |
ADEA Gies Foundation/AADR Academic Dental Careers Fellowship Program (Faculty mentor and ADEA liaison). Dr. Peterson’s national role in interprofessional education was highlighted at Opening Session of Am Dent Educ Assoc annual meeting (San Diego, CA) (2011) | American Dental Education Association |
Fellowship in Dental Surgery without Examination (Edinburgh, Scotland) (2011) | Royal College of Surgeons of Edinburgh |
Honorary Chair, Scientific Committee. 2nd Congress of the Hellenic Association of Supportive Care of the Oral Cavity in Cancer (Athens, Greece) (2010) | Hellenic Association of Supportive Care of the Oral Cavity in Cancer |
Invited honorary lecture: "Honouring the Past-Building for the Future" (London, England) (2010) | European Association of Oral Medicine |
Invited Prestige Seminar: "Meet the Oncology Expert" (Brussels, Belgium) (2009) | Institut Jules Bordet |
Distinguished Achievement Award (Houston, TX) (2008) | Multinational Association of Supportive Care in Cancer |
Invited keynote lecture: Israeli Society of Oral Medicine international conference (Tel Aviv, Israel) (2008) | Israeli Society of Oral Medicine |
Physician of the Year Award (2006) | CancerCare |
Visiting Professor (Charlotte, NC) (2006) | Carolinas Medical Center, Charlotte, North Carolina |
Samuel C. Miller Award for significant contribution to the art and science of Oral Medicine (highest academic award of the Academy) (Key Biscayne, FL) (2004) | American Academy of Oral Medicine |
Visiting Professor, King Faisal Specialist Hospital & Research Center (Jeddah and Riyadh, Saudi Arabia) (2001) | King Faisal Specialist Hospital & Research Center, Saudi Arabia |
Gigliotti Memorial Award for Excellence in Dental Education (Baltimore, MD) (1989) | Univ. of Maryland Dental School |
OKU Honorary Scholastic Dental Society (Baltimore, MD) (1980) | Omicron Kappa Upsilon |
NIH PHS Training Grant #DE-281: Clinical Specialty (Oral Medicine) & Ph.D. (Experimental Pathology) (1972) | National Institutes of Health |
NIH Fellowship in Biology: Predoctoral Research Associate (1971) | National Institutes of Health |
NIH Fellowship in Biology, Predoctoral Research Associate (1970) | National Institutes of Health |
Journal Articles
-
Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 Jun;42(16):1975-1996
-
Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline Clinical Insights.
JCO oncology practice 2024 May;OP2400182
-
Gaps in Access to Medically Necessary Dental Care for Patients Living With and Beyond Cancer: We Must Do Better.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 Apr;JCO2400162
-
World Workshop on Oral Medicine VIII: Barriers to research in oral medicine: results from a global survey.
Oral surgery, oral medicine, oral pathology and oral radiology 2023 Nov;136(5):584-594
-
Use of Biosimilar Medications in Oncology.
JCO oncology practice 2022 Jan;OP2100771
-
Embracing multi-causation of periodontitis: Why aren't we there yet?
Oral diseases 2021 Dec;
-
Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial.
Bone marrow transplantation 2021 Nov;
-
Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Jul;JCO2101208
-
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Apr;39(10):1165-1184
-
The Salivary Mycobiome Contains 2 Ecologically Distinct Mycotypes.
Journal of dental research 2020 Apr;99(6):730-738
-
ASCO Clinical Practice Guideline Endorsements and Adaptations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Dec;JCO1902839
-
Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2019 Dec;
-
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary.
Journal of oncology practice 2019 Nov;15(11):603-606
-
Response to "Prognostic biomarkers in oral leukoplakia".
Oral diseases 2019 Aug;
-
Medication-Related Osteonecrosis of the Jaws.
Journal of the National Cancer Institute. Monographs 2019 Aug;2019(53):
-
Oral Mucosal Injury Caused by Targeted Cancer Therapies.
Journal of the National Cancer Institute. Monographs 2019 Aug;2019(53):
-
Research Frontiers in Oral Toxicities of Cancer Therapies: Osteoradionecrosis of the Jaws.
Journal of the National Cancer Institute. Monographs 2019 Aug;2019(53):
-
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Jul;JCO1901186
-
Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy.
Journal of fungi (Basel, Switzerland) 2019 Jun;5(2):
-
World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies.
Oral diseases 2019 Jun;25 Suppl 164-78
-
World Workshop on Oral Medicine VII: Targeting the microbiome for oral medicine specialists-Part 1. A methodological guide.
Oral diseases 2019 Jun;25 Suppl 112-27
-
World Workshop on Oral Medicine VII: Targeting the oral microbiome Part 2: Current knowledge on malignant and potentially malignant oral disorders.
Oral diseases 2019 Jun;25 Suppl 128-48
-
Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.
Microbiome 2019 Apr;7(1):66
-
World Workshop on Oral Medicine VII: Biomarkers predicting lymphoma in the salivary glands of patients with Sjögren's syndrome. A systematic review.
Oral diseases 2019 Jan;
-
Honoring a champion of Oral Medicine: Professor Crispian Scully.
Oral diseases 2018 Mar;24(1-2):282-284
-
Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model.
Molecular oral microbiology 2018 Jan;33212-223
-
Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients.
Analytical and bioanalytical chemistry 2015 Jul;407(23):7239-43
-
World Workshop on Oral Medicine VI: Controversies regarding dental management of medically complex patients: assessment of current recommendations.
Oral surgery, oral medicine, oral pathology and oral radiology 2015 Mar;120(2):207-26
-
Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014 Dec;21(3):503-8
-
Report on World Workshops on Oral Medicine (WWOM) IV and V: research themes and citation impact: WWOM VI steering committee.
Oral diseases 2014 May;21(4):409-16
-
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Cancer 2014 May;120(10):1453-61
-
Chemotherapy or radiation-induced oral mucositis.
Dental clinics of North America 2014 Apr;58(2):341-9
-
Use of archived biopsy specimens to study gene expression in oral mucosa from chemotherapy-treated cancer patients.
Oral surgery, oral medicine, oral pathology and oral radiology 2013 May;115(5):630-7
-
Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2013 Jan;21(1):327-32
-
A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012 Aug;20(8):1797-804
-
Using high throughput sequencing to explore the biodiversity in oral bacterial communities.
Molecular oral microbiology 2012 Jun;27(3):182-201
-
Supportive care treatment guidelines: value, limitations, and opportunities.
Seminars in oncology 2011 Jun;38(3):367-73
-
Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010 Aug;18(8):1089-98
-
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.
Annals of Oncology 2010 Jan;21(SUPPL. 5):
-
Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010 Jan;18(1):95-103
-
Patterns of sore mouth in outpatients with cancer receiving chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009 Apr;17(4):413-28
-
Application of multilevel growth-curve analysis in cancer treatment toxicities: the exemplar of oral mucositis and pain.
Oncology nursing forum 2009 Jan;36(1):E11-9
-
The experience of a sore mouth and associated symptoms in patients with cancer receiving outpatient chemotherapy.
Cancer nursing 2009 Jan;32(4):259-70
-
Pilot randomized phase II study of celecoxib in oral premalignant lesions.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Apr;14(7):2095-101
-
Management of dental patients taking common hemostasis-altering medications.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2007 Mar;103 Suppl(SUPPL.):S45.e1-11
-
Updated clinical practice guidelines for the prevention and treatment of mucositis.
Cancer 2007 Mar;109(5):820-31
-
Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy.
Cancer 2007 Jan;109(2):322-31
-
Visual graphical analysis: a technique to investigate symptom trajectories over time.
Nursing research 2007 Jan;56(3):195-201
-
Major salivary gland damage in allogeneic hematopoietic progenitor cell transplantation assessed by scintigraphic methods.
Bone marrow transplantation 2006 May;37(10):955-9
-
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.
Cancer 2004 May;100(9 Suppl):2026-46
-
The 20 item oral mucositis index: reliability and validity in bone marrow and stem cell transplant patients.
Cancer investigation 2002 Jan;20(7-8):893-903
-
Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Cancer 2001 Aug;92(4):875-85
-
Maintaining study validity in a changing clinical environment.
Nursing research 2000 Jan;49(4):231-5
-
Routine dental diagnostic imaging in hematopoietic cell transplantation.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 1999 Oct;88(4):376-8
-
Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group.
Cancer 1999 May;85(10):2103-13
-
The Minasian/Dwyer Article Reviewed.
ONCOLOGY 1998 Jan;12(8):1162-1165
-
Effects of sanguinarium, chlorhexidine and tetracycline on neutrophil viability and functions in vitro.
Journal of periodontal research 1997 Apr;32(3):335-44
-
Postextraction osteomyelitis in a bone marrow transplant recipient.
Oral surgery, oral medicine, and oral pathology 1993 Mar;75(3):391-6
-
Capnocytophaga bacteremia in a patient with Hodgkin's disease following bone marrow transplantation: case report and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992 May;14(5):1045-9
-
Effect of granulocytopenia on oral microbial relationships in patients with acute leukemia.
Oral surgery, oral medicine, and oral pathology 1990 Dec;70(6):720-3
Book Chapters
-
Oral complications of nonsurgical cancer therapies.
Burket's Oral Medicine (13th ed). 2021 Aug;259-280.
-
Oral complications of nonsurgical cancer therapies: Diagnosis and treatment.
Burket’s Oral Medicine (12th ed). 2015 Jan;pp. 201-218
-
Oral complications in immunocompromised patients: The oncology protype.
The Oral-Systemic Health Connection 2014 Feb;220-237
-
New frontiers in mucositis.
2012 Am Soc Clin Oncol Educ Book 2012 May;545-551
Conference Papers
-
Mucosal damage: a major risk factor for severe complications after cytotoxic therapy.
Seminars in oncology 2004 Jun;31(3 Suppl 8):35-44
-
Seminars in Oncology Nursing: Introduction
Seminars in Oncology Nursing 2004 Jan;20(1):1-2
-
Future research directions.
Journal of the National Cancer Institute. Monographs 2001 Jan;(29):3-5
-
Cancer therapies for the 21st Century. 9th annual meeting of the International Society for Oral Oncology, 2-4 June 1994, National Institutes of Health, Bethesda, Maryland, U.S.A.
European journal of cancer. Part B, Oral oncology 1995 Jul;31B(4):286-7
-
Prevention of oral complications in cancer patients.
Preventive medicine 1994 Sep;23(5):763-5
-
Oral infections in the immunocompromised host. International Association for Dental Research Symposium 19 April 1991, Acapulco, Mexico.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1992 May;21(5):193-8
-
Pretreatment strategies for infection prevention in chemotherapy patients.
NCI monographs : a publication of the National Cancer Institute 1990 Jan;(9):61-71
Editorials
-
World Workshop on Oral Medicine VII: Editorial.
Oral diseases 2019 Jun;25 Suppl 11-7
-
Sixth World Workshop on Oral Medicine: historical context.
Oral surgery, oral medicine, oral pathology and oral radiology 2015 Aug;120(2):125-31
-
The new world of dental medicine and oncology
Acta Stomatologica Croatica 2013 Nov;47199-200
-
Xerostomia--any progress?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003 Apr;11(4):199-200
-
Oral problems in supportive care: no longer an orphan topic?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2000 Sep;8(5):347-8
-
Oral infection.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999 Jul;7(4):217-8
Letters
-
Reply to Fusco et al.
JCO oncology practice 2020 Jan;JOP1900716
Notes
-
Palifermin in myelotoxic therapy induced oral mucositis.
Drugs 2005 Jan;65(15):2147-2149
Reviews
-
Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.
Oral surgery, oral medicine, oral pathology and oral radiology 2018 Apr;125650-669
-
Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.
Cancer medicine 2016 Aug;5(8):1897-907
-
Oral medicine (stomatology) across the globe: birth, growth, and future.
Oral surgery, oral medicine, oral pathology and oral radiology 2016 Feb;121(2):149-157.e5
-
Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Jul;26 Suppl 5(suppl 5):v139-51
-
Oral mucosal injury in oncology patients: perspectives on maturation of a field.
Oral diseases 2015 Mar;21(2):133-41
-
Oral mucosal injury in oncology patients
Curr Oral Health Rep 2014 Sep;1190-195
-
Oral mucosal injury caused by cancer therapies: current management and new frontiers in research.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2014 Feb;43(2):81-90
-
Genetics/epigenetics of oral premalignancy: current status and future research.
Oral diseases 2011 Apr;17 Suppl 17-22
-
Oral mucositis: The new paradigms.
Current Opinion in Oncology 2010 Jan;22(4):318-322
-
Bisphosphonate osteonecrosis (BON): unanswered questions and research possibilities.
Reviews on recent clinical trials 2009 May;4(2):99-109
-
Management of oral mucositis in patients who have cancer.
Dental clinics of North America 2008 Jan;52(1):61-77, viii
-
Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006 Jun;14(6):499-504
-
New strategies for management of oral mucositis in cancer patients.
The journal of supportive oncology 2006 Feb;4(2 Suppl 1):9-13
-
Treatment of mucositis, including new medications.
Cancer Journal 2006 Jan;12(5):348-354
-
Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Cancer 2005 Jul;104(1):83-93
-
Oral and gastrointestinal mucositis: Novel insights into pathophysiology and potential therapies
Advanced Studies in Medicine 2005 Jan;5(4 B):
-
Oral mucositis.
Dental clinics of North America 2005 Jan;49(1):167-84, ix
-
Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
Cancer 2004 May;100(9 Suppl):1995-2025
-
Evidence-based guidelines for managing mucositis.
Seminars in oncology nursing 2004 Feb;20(1):59-66
-
Novel therapies.
Seminars in oncology nursing 2004 Feb;20(1):53-8
-
Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions.
Oral oncology 2003 Feb;39(2):91-100
-
Research advances in oral mucositis.
Current opinion in oncology 1999 Jul;11(4):261-6
-
Acute oral pain and mucositis in bone marrow transplant and leukemia patients: data from a pilot study.
Cancer nursing 1998 Dec;21(6):385-93
-
Nonsurgical management of head and neck cancer patients.
Dental clinics of North America 1994 Jul;38(3):425-45
-
Diagnosis and management of acute and chronic oral complications of nonsurgical cancer therapies.
Dental clinics of North America 1992 Oct;36(4):945-66
-
Oral toxicity of chemotherapeutic agents.
Seminars in oncology 1992 Oct;19(5):478-91
-
Oral candidiasis.
Clinics in geriatric medicine 1992 Aug;8(3):513-27